Add to Favourites
To login click here
The global artificial intelligence in life sciences industry is expected to reach USD 9.80 billion by 2032 with a CAGR of 20.21% from 2024 to 2032. AI is revolutionizing the industry by using machine learning to analyze biological data, integrate clinical records, and discover new medicine and drug targets. The key technology driving this growth is machine learning, but policies must be developed to protect intellectual property rights.